ArticleMolecular therapy oncolytics2022
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.
Haruka Shinohara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it